Suppr超能文献

相似文献

1
Kinetic control in protein folding for light chain amyloidosis and the differential effects of somatic mutations.
J Mol Biol. 2014 Jan 23;426(2):347-61. doi: 10.1016/j.jmb.2013.10.016. Epub 2013 Oct 22.
2
Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.
Protein Sci. 2015 Nov;24(11):1829-40. doi: 10.1002/pro.2790. Epub 2015 Sep 7.
4
Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans.
J Biol Chem. 2015 Feb 20;290(8):4953-4965. doi: 10.1074/jbc.M114.615401. Epub 2014 Dec 23.
6
Thermal stability threshold for amyloid formation in light chain amyloidosis.
Int J Mol Sci. 2013 Nov 15;14(11):22604-17. doi: 10.3390/ijms141122604.
8
Immunoglobulin light chain amyloid aggregation.
Chem Commun (Camb). 2018 Sep 20;54(76):10664-10674. doi: 10.1039/c8cc04396e.
9
Tyrosine residues mediate fibril formation in a dynamic light chain dimer interface.
J Biol Chem. 2012 Aug 10;287(33):27997-8006. doi: 10.1074/jbc.M112.362921. Epub 2012 Jun 27.
10
Recruitment of Light Chains by Homologous and Heterologous Fibrils Shows Distinctive Kinetic and Conformational Specificity.
Biochemistry. 2016 May 31;55(21):2967-78. doi: 10.1021/acs.biochem.6b00090. Epub 2016 May 16.

引用本文的文献

1
Clone-specific residue changes at multiple positions are associated with amyloid formation by antibody light chains.
Front Immunol. 2025 Aug 1;16:1622207. doi: 10.3389/fimmu.2025.1622207. eCollection 2025.
2
Biophysical characterization of human-cell-expressed, full-length κI O18/O8, AL-09, λ6a, and Wil immunoglobulin light chains.
Biochim Biophys Acta Proteins Proteom. 2024 May 1;1872(3):140993. doi: 10.1016/j.bbapap.2023.140993. Epub 2023 Dec 31.
4
Pharmacological stabilization of the native state of full-length immunoglobulin light chains to treat light chain amyloidosis.
Curr Opin Chem Biol. 2023 Aug;75:102319. doi: 10.1016/j.cbpa.2023.102319. Epub 2023 Jun 6.
5
Molecular Research on Amyloidosis.
Int J Mol Sci. 2023 Apr 10;24(8):6980. doi: 10.3390/ijms24086980.
6
Calorimetric Markers for Detection and Monitoring of Multiple Myeloma.
Cancers (Basel). 2022 Aug 11;14(16):3884. doi: 10.3390/cancers14163884.
7
Molecular Mechanism of Pathogenesis and Treatment Strategies for AL Amyloidosis.
Int J Mol Sci. 2022 Jun 6;23(11):6336. doi: 10.3390/ijms23116336.
8
9
AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies: State-of-the-Art Review.
JACC CardioOncol. 2021 Oct 19;3(4):467-487. doi: 10.1016/j.jaccao.2021.09.003. eCollection 2021 Oct.

本文引用的文献

2
Tyrosine residues mediate fibril formation in a dynamic light chain dimer interface.
J Biol Chem. 2012 Aug 10;287(33):27997-8006. doi: 10.1074/jbc.M112.362921. Epub 2012 Jun 27.
3
Supramolecular non-amyloid intermediates in the early stages of α-synuclein aggregation.
Biophys J. 2012 Mar 7;102(5):1127-36. doi: 10.1016/j.bpj.2012.01.051. Epub 2012 Mar 6.
4
Glycosaminoglycans promote fibril formation by amyloidogenic immunoglobulin light chains through a transient interaction.
Biophys Chem. 2011 Sep;158(1):81-9. doi: 10.1016/j.bpc.2011.05.011. Epub 2011 May 18.
7
Kinetic hysteresis in collagen folding.
Biophys J. 2010 Jun 16;98(12):3004-14. doi: 10.1016/j.bpj.2010.03.019.
8
A single mutation promotes amyloidogenicity through a highly promiscuous dimer interface.
Structure. 2010 May 12;18(5):563-70. doi: 10.1016/j.str.2010.02.012.
9
Protein kinetic stability.
Biophys Chem. 2010 May;148(1-3):1-15. doi: 10.1016/j.bpc.2010.02.004. Epub 2010 Feb 11.
10
How antibodies fold.
Trends Biochem Sci. 2010 Apr;35(4):189-98. doi: 10.1016/j.tibs.2009.11.005. Epub 2009 Dec 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验